Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma. Liu GM, Zeng HD, Zhang CY, Xu JW, et al. Dig Dis Sci 2020 Apr 24. pii: 10.1007/s10620-020-06260.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu GM, Zeng HD, Zhang CY, Xu JW, et al. Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma. Dig Dis Sci 2020 Apr 24. pii: 10.1007/s10620-020-06260.
PMID: 32333311